Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trials

TSEN-FANG TSAI2018-09-102018-09-102015http://www.scopus.com/inward/record.url?eid=2-s2.0-84945470478&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/395834Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trialsjournal article10.1111/bjd.14018